Drugs / EMD 1204831
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01110083 | Apr 2010 → Mar 2012 | cancer | EMD Serono | Terminated | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EMD 1204831 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01110083 ↗ |
| Action | Inhibit | “c-Met Kinase Inhibitor EMD 1204831” NCT01110083 ↗ |
| Modality | Small molecule | — CHEMBL3960488 ↗ |
| Target | MET | “c-Met Kinase Inhibitor EMD 1204831” NCT01110083 ↗ |